Identifying and Controlling CPPs and CMAs.

Bibliographic Details
Published in:BioPharm International Vol. 31; no. 3; pp. 38 - 42
Main Author: Little, Thomas A.
Format: Journal Article
Published: MJH Life Sciences Mar2018
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128480952&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128480952
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Mar2018
      vid: 31
      iid: 3
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        128480952
        128480952
      ppf: 38
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Identifying and Controlling CPPs and CMAs.
      aug:
        au: Little, Thomas A.
        affil: President/CEO of Thomas A. Little Consulting, BioAssay Sciences, 12401 N Wildflower Lane Highland, UT 84003, 1.925.285.1847
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N